Metastatic Cervical Carcinoma
12 clinical trials · Condition
◉ Watch Metastatic Cervical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Donafenib for Recurrent Cervical Cancer (NCT05310331) | Lei Li | 2022-03-27 |
| Tislelizumab and Radiotherapy for Recurrent Cervical Cancer (NCT05310383) | Lei Li | 2022-03-27 |
| PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer (NCT05310305) | Lei Li | 2022-03-26 |
| Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer (NCT04574635) | Mayo Clinic | 2020-11-17 |
| Paclitaxel Therapeutic Drug Monitoring in Cancer Patients (NCT03987555) | Wake Forest University Health Sciences | 2019-11-11 |
Track Metastatic Cervical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.